XBI

3 Great ETFs for a Biotech Rebound – BBP CNCR XBI

By Todd Shriber, InvestorPlace Contributor
Biotech stocks and ETFs have recently been rebounding in impressive fashion. Tactical investors might want to take a look at BBP, XBI and CNCR.

SPDR S&P Biotech (ETF) (XBI) – The Best Biotech Investment Now

By Jeff Reeves
The best biotech stocks are hard to identify, but the XBI ETF allows investors to make a diversified but aggressive bet on small, high-growth biotech stocks.

7 Low-Risk Healthcare Stocks to Buy Now

By Jeff Reeves
If you're looking for solid stocks to buy in an uncertain market, healthcare offers built-in growth and, often, safe dividends.

IBB: Another Biotech Bloodbath Beckons

By Tyler Craig, Tales of a Technician
Biotech stocks are poised for another downturn. Profit with this IBB stock put spread.

Why Now Is the Time to Pile Back Into Biotech Stocks (IBB, XBI)

By John Divine, InvestorPlace Assistant Editor
For years, biotech stocks have outperformed the market. In light of their recent downturn, now's a fine time to buy biotech ETFs like IBB and XBI.

Bet on a Bounce with These Biotech ETFs

By Todd Shriber, InvestorPlace Contributor
Biotech stocks may have taken a beating lately, but that may just make these biotech ETFs more of a bargain.

Be Careful Before Loving Leveraged Biotech ETFs

By Todd Shriber, InvestorPlace Contributor
The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs.

Biotech Stocks: Is It Safe to Come out Now? (IBB, XBI)

By James Brumley, InvestorPlace Feature Writer
Biotech stocks are getting smashed this week, but betting against the sector remains a bad idea. The only trick is getting the timing right.

The Best Way to Buy Biotech Stocks: A Heated Debate

By Todd Shriber, InvestorPlace Contributor
Among ETFs that hold biotech stocks, XBI looks like a winner, holding the advantages of equal-weighting and exposure to some potential highfliers.

7 Dirt-Cheap Ways to Supercharge Your Portfolio

By Kyle Woodley, Senior Investing Editor, Kiplinger
Looking to juice your dividends? Get aggressive with growth? Well, these are some of the best ETFs to get the job done on the cheap.

The 7 Best ETFs to Buy for June

By Jeff Reeves
The best ETFs to buy as we head into summer are those that are on the right side of some powerful macro trends. Here are seven that fit that bill right now.

Biotech Stocks Set to Soar, So Buy This Top Biotech ETF

By Jeff Reeves
Biotech stocks are NOT in a bubble, and the XBI biotech ETF is a cheap and diversified way to play the long-term potential of biotechnology.

The Best ETFs of 2015’s First Quarter

By Will Ashworth, InvestorPlace Contributor
The best ETFs so far in 2015 are bundled in the healthcare, consumer discretionary and telecom sectors. Here's who has led the charge in Q1.

3 Biotech Stocks That Could Pop in a Heartbeat

By Johnson Research Group
Short sellers are making fools' bets against biotech stocks, which are looking stronger than the broader market. Investors should target MYGN, THRX, GHDX ... and even the whole sector via XBI.

5 Best ETFs to Buy Now

By Jeff Reeves
These five ETFs to buy now all fit together very nicely to form a good foundation for your portfolio -- and individually, these five funds all offer a lot of upside potential regardless of your investment goals.

XBI – Your Best ETF to Buy Now

By Jeff Reeves
The XBI biotech ETF is your best way to tap into the growth of healthcare and the stability of a good, cheap exchange traded fund.

5 Best Biotech Stocks to Buy Now

By Jeff Reeves
Discovery why biotech stocks are unlikely candidates for blowout performance in 2015.

5 Best ETFs to Buy Right Now

By Jeff Reeves
If you want to beat the market, check out these five best ETFs across several different investment flavors.

Biotech ETFs – Keep Those Buyouts Coming!

By David Fabian, FMD Capital Management
Merck's buyout of Idenix didn't just pump up IDIX shares -- it also had a great double effect on biotech ETFs such as XBI that usually are buoyed by M&A.
Load More